Copyright Reports & Markets. All rights reserved.

Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 CTC Enrichment
    • 1.4.3 CTC Detection
  • 1.5 Market by Application
    • 1.5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and clinics
    • 1.5.3 Pharmaceuticals and biotechnology companies
    • 1.5.4 Academic research institutes
    • 1.5.5 CROs
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Regions
    • 2.2.1 Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Circulating Tumor Cell (CTC) Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Circulating Tumor Cell (CTC) Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Market Size
    • 3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
    • 3.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
  • 3.3 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 6.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 7.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 8.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in China (2019-2020)
  • 8.3 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 9.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

10 SoutheastAsia

  • 10.1 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 10.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in SoutheastAsia (2019-2020)
  • 10.3 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 10.4 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 11.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in India (2019-2020)
  • 11.3 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

12 Central& South America

  • 12.1 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
  • 12.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Central& South America (2019-2020)
  • 12.3 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 ApoCell, Inc.(US)
    • 13.1.1 ApoCell, Inc.(US) Company Details
    • 13.1.2 ApoCell, Inc.(US) Business Overview
    • 13.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020))
    • 13.1.5 ApoCell, Inc.(US) Recent Development
  • 13.2 Biocep Ltd. (Israel)
    • 13.2.1 Biocep Ltd. (Israel) Company Details
    • 13.2.2 Biocep Ltd. (Israel) Business Overview
    • 13.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.2.5 Biocep Ltd. (Israel) Recent Development
  • 13.3 Biocept, Inc.(US)
    • 13.3.1 Biocept, Inc.(US) Company Details
    • 13.3.2 Biocept, Inc.(US) Business Overview
    • 13.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.3.5 Biocept, Inc.(US) Recent Development
  • 13.4 Biofluidica MicrotechnologiesLLc(US)
    • 13.4.1 Biofluidica MicrotechnologiesLLc(US) Company Details
    • 13.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
    • 13.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
  • 13.5 Celltraffix Inc.(US)
    • 13.5.1 Celltraffix Inc.(US) Company Details
    • 13.5.2 Celltraffix Inc.(US) Business Overview
    • 13.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.5.5 Celltraffix Inc.(US) Recent Development
  • 13.6 ClearbridgeBiomedics(Singapore)
    • 13.6.1 ClearbridgeBiomedics(Singapore) Company Details
    • 13.6.2 ClearbridgeBiomedics(Singapore) Business Overview
    • 13.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.6.5 ClearbridgeBiomedics(Singapore) Recent Development
  • 13.7 Creatv Microtech, Inc.(US)
    • 13.7.1 Creatv Microtech, Inc.(US) Company Details
    • 13.7.2 Creatv Microtech, Inc.(US) Business Overview
    • 13.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.7.5 Creatv Microtech, Inc.(US) Recent Development
  • 13.8 CynvenioBiosystems, Inc.(US)
    • 13.8.1 CynvenioBiosystems, Inc.(US) Company Details
    • 13.8.2 CynvenioBiosystems, Inc.(US) Business Overview
    • 13.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.8.5 CynvenioBiosystems, Inc.(US) Recent Development
  • 13.9 EpicBiosciencesInc.(US)
    • 13.9.1 EpicBiosciencesInc.(US) Company Details
    • 13.9.2 EpicBiosciencesInc.(US) Business Overview
    • 13.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.9.5 EpicBiosciencesInc.(US) Recent Development
  • 13.10 FluxionBiosciences, Inc.(US)
    • 13.10.1 FluxionBiosciences, Inc.(US) Company Details
    • 13.10.2 FluxionBiosciences, Inc.(US) Business Overview
    • 13.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 13.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 13.10.5 FluxionBiosciences, Inc.(US) Recent Development
  • 13.11 Ikonisys, Inc.(US)
    • 10.11.1 Ikonisys, Inc.(US) Company Details
    • 10.11.2 Ikonisys, Inc.(US) Business Overview
    • 10.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.11.5 Ikonisys, Inc.(US) Recent Development
  • 13.12 IVDiagnostics, Inc.(US)
    • 10.12.1 IVDiagnostics, Inc.(US) Company Details
    • 10.12.2 IVDiagnostics, Inc.(US) Business Overview
    • 10.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.12.5 IVDiagnostics, Inc.(US) Recent Development
  • 13.13 JanssenDiagnosticsLLc(US)
    • 10.13.1 JanssenDiagnosticsLLc(US) Company Details
    • 10.13.2 JanssenDiagnosticsLLc(US) Business Overview
    • 10.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.13.5 JanssenDiagnosticsLLc(US) Recent Development
  • 13.14 QIAGEnHannoverGmbH (Germany)
    • 10.14.1 QIAGEnHannoverGmbH (Germany) Company Details
    • 10.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
    • 10.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
  • 13.15 RARECELLsSAs(Italy)
    • 10.15.1 RARECELLsSAs(Italy) Company Details
    • 10.15.2 RARECELLsSAs(Italy) Business Overview
    • 10.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.15.5 RARECELLsSAs(Italy) Recent Development
  • 13.16 ScreenCell(France)
    • 10.16.1 ScreenCell(France) Company Details
    • 10.16.2 ScreenCell(France) Business Overview
    • 10.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.16.5 ScreenCell(France) Recent Development
  • 13.17 STEMCELlTechnologies, Inc.(Canada)
    • 10.17.1 STEMCELlTechnologies, Inc.(Canada) Company Details
    • 10.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
    • 10.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
    • 10.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
    • 10.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Circulating Tumor Cell (CTC) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell (CTC) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    ApoCell, Inc.(US)
    Biocep Ltd. (Israel)
    Biocept, Inc.(US)
    Biofluidica MicrotechnologiesLLc(US)
    Celltraffix Inc.(US)
    ClearbridgeBiomedics(Singapore)
    Creatv Microtech, Inc.(US)
    CynvenioBiosystems, Inc.(US)
    EpicBiosciencesInc.(US)
    FluxionBiosciences, Inc.(US)
    Ikonisys, Inc.(US)
    IVDiagnostics, Inc.(US)
    JanssenDiagnosticsLLc(US)
    QIAGEnHannoverGmbH (Germany)
    RARECELLsSAs(Italy)
    ScreenCell(France)
    STEMCELlTechnologies, Inc.(Canada)

    Market segment by Type, the product can be split into
    CTC Enrichment
    CTC Detection
    Market segment by Application, split into
    Hospitals and clinics
    Pharmaceuticals and biotechnology companies
    Academic research institutes
    CROs

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    SoutheastAsia
    India
    Central& South America

    Buy now